Caroline I.
- Country
- Sweden
- Department
- Studieenheten Akademiskt specialistcentrum, SLSO
Research Overview
- Phase 1b Open-Label Study of VRG50635 in Sporadic and Familial Amyotrophic Lateral Sclerosis Patients with Long-Term Treatment
- Phase 1 Study on Safety, Pharmacokinetics, and Pharmacodynamics of Siplizumab in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis Patients
- A Phase 2b Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Usnoflast in Adults with Amyotrophic Lateral Sclerosis
Data & Insights
Has run more than one trial at 39 of 68 partner sites.
Specializations
Neurodegenerative Disease Research
This investigator specializes in clinical research focused on Amyotrophic Lateral Sclerosis (ALS), conducting extensive therapeutic investigations into novel treatment approaches for this progressive neurological condition.
- Disease Progression Assessment
- Survival Rate Evaluation
- Respiratory Function Monitoring
Their work encompasses evaluation of therapeutic interventions targeting various aspects of ALS pathology.
Therapeutic Development
The investigator leads research into multiple experimental therapeutic compounds for ALS treatment, including both novel and existing drug candidates adapted for neurodegenerative conditions.
- Drug Safety Assessment
- Treatment Tolerability Studies
- Long-term Therapeutic Outcomes
Their research includes evaluation of intravenous therapies and oral medications for ALS management.
Clinical Outcomes Research
The investigator focuses on measuring therapeutic efficacy through comprehensive assessment of patient outcomes and survival metrics in ALS treatment.
- Ventilation-free Survival Analysis
- Functional Assessment Methods
- Quality of Life Evaluation
Their research encompasses both short-term and extended treatment protocols in ALS clinical care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.